Centene Co. (NYSE:CNC) Holdings Decreased by First Bank & Trust

First Bank & Trust decreased its holdings in shares of Centene Co. (NYSE:CNCFree Report) by 8.1% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 3,735 shares of the company’s stock after selling 329 shares during the period. First Bank & Trust’s holdings in Centene were worth $281,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. Wealth Enhancement Advisory Services LLC increased its position in Centene by 11.4% in the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 38,582 shares of the company’s stock valued at $3,028,000 after acquiring an additional 3,963 shares during the period. 180 Wealth Advisors LLC bought a new position in Centene in the 1st quarter valued at about $202,000. Vicus Capital raised its position in shares of Centene by 19.1% during the 1st quarter. Vicus Capital now owns 3,501 shares of the company’s stock worth $275,000 after buying an additional 562 shares in the last quarter. Diversified Trust Co increased its stake in shares of Centene by 30.6% during the first quarter. Diversified Trust Co now owns 20,624 shares of the company’s stock valued at $1,619,000 after acquiring an additional 4,828 shares during the period. Finally, Oliver Luxxe Assets LLC lifted its holdings in shares of Centene by 1.0% in the first quarter. Oliver Luxxe Assets LLC now owns 46,214 shares of the company’s stock valued at $3,627,000 after buying an additional 449 shares during the period. 93.63% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

CNC has been the subject of several research reports. Stephens restated an “equal weight” rating and set a $78.00 price objective on shares of Centene in a research report on Monday, August 5th. JPMorgan Chase & Co. cut their price target on shares of Centene from $85.00 to $80.00 and set a “neutral” rating on the stock in a report on Wednesday, July 10th. Wells Fargo & Company lowered their price objective on shares of Centene from $93.00 to $91.00 and set an “overweight” rating on the stock in a research report on Friday, September 13th. Robert W. Baird decreased their target price on Centene from $83.00 to $66.00 and set a “neutral” rating for the company in a research report on Friday. Finally, Cantor Fitzgerald reiterated an “overweight” rating and issued a $90.00 price objective on shares of Centene in a research note on Tuesday, October 1st. Seven investment analysts have rated the stock with a hold rating, six have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $84.17.

Get Our Latest Research Report on Centene

Centene Stock Performance

NYSE:CNC opened at $64.22 on Friday. The firm has a market capitalization of $34.27 billion, a PE ratio of 12.77, a PEG ratio of 0.98 and a beta of 0.48. The company has a current ratio of 1.17, a quick ratio of 1.17 and a debt-to-equity ratio of 0.64. Centene Co. has a 1 year low of $59.77 and a 1 year high of $81.42. The firm’s fifty day simple moving average is $72.88 and its 200 day simple moving average is $72.31.

Centene (NYSE:CNCGet Free Report) last released its earnings results on Friday, October 25th. The company reported $1.62 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.39 by $0.23. Centene had a return on equity of 14.45% and a net margin of 1.79%. The firm had revenue of $42.02 billion for the quarter, compared to analyst estimates of $37.91 billion. On average, sell-side analysts anticipate that Centene Co. will post 6.8 EPS for the current year.

About Centene

(Free Report)

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.

See Also

Want to see what other hedge funds are holding CNC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Centene Co. (NYSE:CNCFree Report).

Institutional Ownership by Quarter for Centene (NYSE:CNC)

Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.